arrow
Back
R

Randi Grøn

Novo Nordisk

8H-index
33Paper Count
403Citation Count
Published Papers 11
Publication Date
The Benefit of Insulin Degludec/Liraglutide (IDegLira) Compared With Basal-Bolus Insulin Therapy is Consistent Across Participant Subgroups With Type 2 Diabetes in the DUAL VII Randomized Trial
err2020-02-28
err8
errOAAI
errBillings, Liana K.; Agner, Bue F. Ross; Altuntas, Yuksel; Gron, Randi; Halladin, Natalie; Klonoff, David C.; Tentolouris, Nikolaos; Jodar, Esteban
errShare
errSave
IDegLira improves patient-reported outcomes while using a simple regimen with fewer injections and dose adjustments compared with basal-bolus therapy
err2019-08-28
err10
errOAAI
errMiller, Eden; Doshi, Ankur; Gron, Randi; Jodar, Esteban; Orsy, Petra; Ranthe, Mattis F.; Sugimoto, Danny; Tentolouris, Nikolaos; Viljoen, Adie; Billings, Liana K.
errShare
errSave
IDegLira Improves Glycemic Control in Japanese Patients with Type 2 Diabetes (T2D) Uncontrolled on Premixed Insulin Therapy
err2019-06-01
err1
PREAI
errWatada, Hirotaka; Agner, Bue F.; Doshi, Ankur; Gron, Randi; Ranthe, Mattis F.; Billings, Liana K.
errShare
errSave
DUAL VIII: Significantly Longer Time to Treatment Intensification with Insulin Degludec/Liraglutide (IDegLira) vs. Insulin Glargine (IGlar U100) in a 104-Week (Wk) Randomized Trial Mirroring Clinical Practice
err2019-06-01
err0
PREAI
errAroda, Vanita R.; Gonzalez-Galvez, Guillermo; Haluzik, Martin; Silver, Robert J.; Gron, Randi; Halladin, Natalie; Orsy, Petra; Sesti, Giorgio
errShare
errSave
Lower rates of cardiovascular events and mortality associated with liraglutide use in patients treated with basal insulin: A DEVOTE subanalysis (DEVOTE 10)
err2019-04-01
err8
errOAAI
errBrown-Frandsen, Kirstine; Emerson, Scott S.; McGuire, Darren K.; Pieber, Thomas R.; Poulter, Neil R.; Pratley, Richard E.; Zinman, Bernard; Ranthe, Mattis F.; Gron, Randi; Lange, Martin; Moses, Alan C.; Orsy, Petra; Buse, John B.
errShare
errSave
Rates of Major Adverse Cardiovascular (CV) Events (MACE) and Mortality with Basal Insulin by Liraglutide Use-A DEVOTE Subanalysis
err2018-07-01
err1
PREAI
errBrown-Frandsen, Kirstine; Emerson, Scott S.; Marso, Steven P.; Mcguire, Darren K.; Pieber, Thomas R.; Poulter, Neil R.; Zinman, Bernard; Gron, Randi; Lange, Martin; Moses, Alan C.; Orsy, Petra; Ranthe, Mattis F.; Pratley, Richard E.
errShare
errSave
Efficacy of IDegLira vs. Basal-Bolus Therapy in Subjects with Type 2 Diabetes in DUAL VII by Baseline Characteristics
err2018-07-01
err0
PREAI
errBillings, Liana K.; Klonoff, David C.; Tentolouris, Nikolaos; Gron, Randi; Halladin, Natalie; Jodar, Esteban
errShare
errSave
Efficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical Trial
err2018-02-26
err145
errOAAI
errBillings, Liana K.; Doshi, Ankur; Gouet, Didier; Oviedo, Alejandra; Rodbard, Helena W.; Tentolouris, Nikolaos; Gron, Randi; Halladin, Natalie; Jodar, Esteban
errShare
errSave
Low Apgar scores in neonates with prenatal antidepressant exposure reply
err2018-01-02
err0
errOAAI
errKessing, Lars Vedel; Gron, Randi; Andersen, Per Kragh
errShare
errSave
Active smoking and risk of breast cancer in a Danish nurse cohort study
err2017-08-22
err27
errOAAI
errAndersen, Zorana Jovanovic; Jorgensen, Jeanette Therming; Gron, Randi; Brauner, Elvira Vaclavik; Lynge, Elsebeth
errShare
errSave
The effects of maternal depression and use of antidepressants during pregnancy on risk of a child small for gestational age
err2013-03-02
err25
PREAI
errJensen, Hans Morch; Gron, Randi; Lidegaard, Ojvind; Pedersen, Lars Henning; Andersen, Per Kragh; Kessing, Lars Vedel
errShare
errSave